Bérangère Bastien.
Head of Biostatistics, TRANSGENE
In which context did you work with Quinten?
Our purpose was to better understand the combined factors of efficacy of one of our products. Quinten was an opportunity to explore the large amount of data generated by our research, without making any kind of initial selection or assumption.
What kind of value did results from Quinten’s engagement?
Beyond classical analyses findings, we have indeed identified a subgroup of patients which is likely to respond significantly better than average to our treatment. This profile of patients will be thoroughly studied in upcoming studies.
We also have been able to confirm other important markers of patient response.
Declaration of absence of interests :
Mrs Bastien states on his honour to have formulated her testimony sincerely and witout reserve. She declares moreover the absence of any kind of interest in the development of Quinten’s activity, neither for her personnally nor for Transgène.
Medical Director, Intercontinental Medical Affairs, SANOFI-AVENTIS
